SURAKSHA — Suraksha Diagnostic Income Statement
0.000.00%
- IN₹17.06bn
- IN₹17.72bn
- IN₹2.52bn
Annual income statement for Suraksha Diagnostic, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 2,232 | 1,901 | 2,187 | 2,521 |
Cost of Revenue | ||||
Gross Profit | 1,573 | 1,560 | 1,846 | 2,226 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 1,875 | 1,754 | 1,799 | 2,061 |
Operating Profit | 357 | 147 | 388 | 459 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 280 | 67.5 | 315 | 414 |
Provision for Income Taxes | ||||
Net Income After Taxes | 208 | 60.6 | 231 | 310 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 208 | 65.2 | 236 | 318 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 208 | 65.2 | 236 | 318 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 4.2 | 1.67 | 4.95 | 6.28 |
Dividends per Share |